title: N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis.
abstract: The amino sugar N-acetylglucosamine (GlcNAc) is an in vitro inducer of the hyphal mode of growth of the opportunistic pathogen Candida albicans. The development of hyphae by C. albicans is considered to contribute to the pathogenesis of mucosal oral candidiasis. GlcNAc is also a commonly used nutritional supplement for the self-treatment of conditions such as arthritis. To date, no study has investigated whether ingestion of GlcNAc has an effect on the in vivo growth of C. albicans or the pathogenesis of a C. albicans infection. Using a murine model of oral candidiasis, we have found that administration of GlcNAc, but not glucose, increased oral symptoms of candidiasis and fungal burden. Groups of mice were given GlcNAc in either water or in a viscous carrier, i.e., 1% methylcellulose. There was a dose-dependent relationship between GlcNAc concentration and the severity of oral symptoms. Mice given the highest dose of GlcNAc, 45.2 mM, also showed a significant increase in fungal burden, and increased histological evidence of infection compared to controls given water alone. We propose that ingestion of GlcNAc, as a nutritional supplement, may have an impact on oral health in people susceptible to oral candidiasis.
authors.affiliation: Teikyo University Institute of Medical Mycology, Hachioji, Tokyo, Japan.
authors.forename: Sanae A
authors.initials: SA
authors.lastname: Ishijima
authors.forename: Kazumi
authors.initials: K
authors.lastname: Hayama
authors.forename: Miki
authors.initials: M
authors.lastname: Takahashi
authors.forename: Ann R
authors.initials: AR
authors.lastname: Holmes
authors.forename: Richard D
authors.initials: RD
authors.lastname: Cannon
authors.forename: Shigeru
authors.initials: S
authors.lastname: Abe
mesh_terms: D000117:Acetylglucosamine / Q000008:administration & dosage*; D000284:Administration, Oral; D000818:Animals; D002176:Candida albicans / Q000187:drug effects / Q000254:growth & development / Q000472:pathogenicity*; D002180:Candidiasis, Oral / Q000382:microbiology* / Q000473:pathology*; D015169:Colony Count, Microbial; D004195:Disease Models, Animal; D005260:Female; D005502:Food; D006651:Histocytochemistry; D006801:Humans; D025301:Hyphae / Q000187:drug effects / Q000254:growth & development; D051379:Mice; D008813:Mice, Inbred ICR; D008853:Microscopy; D014059:Tongue / Q000473:pathology; D014774:Virulence
chemical_list: D000117:Acetylglucosamine